Nan Fung Group Holdings’s ALX Oncology ALXO Stock Holding History

Nan Fung Group Holdings’s Portfolio ALXO Stock Details ALXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-41,950	Closed	-$26.1K	–	22
2025 Q1	$26.1K	Hold	41,950	–	–	0.02%	35
2024 Q4	$70.1K	Hold	41,950	–	–	0.06%	34
2024 Q3	$76.3K	Hold	41,950	–	–	0.07%	38
2024 Q2	$253K	Hold	41,950	–	–	0.27%	35
2024 Q1	$468K	Hold	41,950	–	–	0.43%	32
2023 Q4	$625K	Hold	41,950	–	–	0.39%	25
2023 Q3	$201K	Hold	41,950	–	–	0.16%	32
2023 Q2	$315K	Hold	41,950	–	–	0.2%	33
2023 Q1	$190K	Hold	41,950	–	–	0.13%	37
2022 Q4	$473K	Hold	41,950	–	–	0.33%	31
2022 Q3	$401K	Hold	41,950	–	–	0.26%	28
2022 Q2	$339K	Hold	41,950	–	–	0.23%	31
2022 Q1	$709K	Hold	41,950	–	–	0.34%	27
2021 Q4	$902K	Hold	41,950	–	–	0.27%	28
2021 Q3	$3.1M	Buy	41,950 +7,000	+20%	+$467K	0.99%	14
2021 Q2	$1.91M	Buy	+34,950	New	+$2.09M	0.59%	15

Other funds holding ALXO

venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Nan Fung Group Holdings's ALXO Position: Q2 2025 in Review

Nan Fung Group Holdings sold out of ALX Oncology (ALXO) in Q2 2025, closing a stake of 41,950 shares — an estimated $26.1K sold.

Nan Fung Group Holdings first reported a position in ALXO in Q2 2021 and held it in 16 quarters. The position peaked at $3.1M in Q3 2021. 61 funds tracked by Wall St. Rank hold ALXO as of Q2 2025.

Nan Fung Group Holdings reported no remaining ALX Oncology position as of Q2 2025 after selling out during the quarter.
Nan Fung Group Holdings sold 41,950 ALX Oncology shares in Q2 2025, an estimated $26.1K.
Nan Fung Group Holdings first reported a position in ALX Oncology in Q2 2021 and held it in 16 quarters.
Nan Fung Group Holdings's ALX Oncology position peaked at $3.1M in Q3 2021.
61 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2025.

Based on Nan Fung Group Holdings's 13F filing for Q2 2025, filed 13 Aug 2025.